Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Long-Term Deferred Tax: 2012

Historic Long-Term Deferred Tax for Agios Pharmaceuticals (AGIO) over the last 1 years, with Dec 2012 value amounting to $2.7 million.

  • Agios Pharmaceuticals' Long-Term Deferred Tax was N/A to $2.7 million in Q3 2013 from the same period last year, while for Sep 2013 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2012, which is N/A change from last year.
  • Per Agios Pharmaceuticals' latest filing, its Long-Term Deferred Tax stood at $2.7 million for FY2012.
  • In the past 5 years, Agios Pharmaceuticals' Long-Term Deferred Tax ranged from a high of $2.7 million in FY2012 and a low of $2.7 million during FY2012.
  • In the last 1 years, Agios Pharmaceuticals' Long-Term Deferred Tax had a median value of $2.7 million in 2012 and averaged $2.7 million.